SHSE:600285 (China)  
Henan Lingrui Pharmaceutical Co Ltd logo

Henan Lingrui Pharmaceutical Co Ltd

¥ 12.46 (-0.72%) Aug 17
P/E:
17.41
P/B:
3.11
Market Cap:
¥ 7.12B ($ 1.05B)
Enterprise V:
¥ 6.31B ($ 930.81M)
Volume:
9.57M
Avg Vol (2M):
8.66M
Volume:
9.57M
Market Cap ¥:
7.12B
Market Cap $:
1.05B
PE Ratio:
17.41
Avg Vol (2-Month):
8.66M
Enterprise Value ¥:
6.31B
Enterprise Value $:
930.81M
PB Ratio:
3.11
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Henan Lingrui Pharmaceutical Co Ltd
NAICS : 325411 SIC : 2834
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Description
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 2,840.704
EPS (TTM) (¥) 0.719
Beta 1.5
Volatility % 43.4
14-Day RSI 59.27
14-Day ATR (¥) 0.375628
20-Day SMA (¥) 11.961
12-1 Month Momentum % 16.67
52-Week Range (¥) 9.57 - 17.97
Shares Outstanding (Mil) 567.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Henan Lingrui Pharmaceutical Co Ltd Filings

Document Form Filing Date
No Filing Data